VEGFA and hepatocellular carcinoma: Treatment with polysaccharide from ASP in an orthotopic hepatocellular carcinoma model of Wistar rats significantly reduced CD34 and VEGF expression in tumor tissues, indicating an anti-angiogenic function for ASP in vivo (29).